Pharmaceutical preparation manufacturing — US Industry Report
The pharmaceutical preparation manufacturing industry in the United States has 1.4K establishments employing 170.0K workers (Census CBP, 2023), with 2026 revenue projected at ~$175.0B. This 33-page report analyzes industry performance, competitive dynamics, and delivers 5-year growth forecasts.
Industry Snapshot
- ▸Geographic concentration of pharma manufacturing employment intensifying across leading regions
- ▸Employment growth in pharma preparation significantly outpacing broader economic expansion
- ▸Establishment count stagnating while pharmaceutical manufacturing employment expands substantially
- ▸Wage growth in pharmaceutical preparation manufacturing diverging sharply from sector productivity gains
Table of Contents
Contents of the Standard report. Chapters marked Standard are not in Basic.
1.Executive Summaryp. 4
Key takeaways, industry definition, and current state overview. Covers the industry's scope, principal activities, NAICS classification context, and a concise snapshot of where the industry stands today. Reading this alone gives decision-makers the high-level picture they need before diving into data-backed chapters.
2.Industry Performancep. 6
Historical performance analysis covering establishments, employment, and payroll (2012-2025). Examines what has driven industry performance in recent years, how the industry has responded to macroeconomic cycles, and which operating conditions have shaped revenue and labor dynamics. Includes source-cited tables and year-by-year data points.
3.Industry Forecastp. 10
5-year projections (2026-2030) with base case, bull case, and bear case scenarios. Each scenario combines historical trends, macroeconomic indicators from FRED, and industry-specific signals. Addresses questions on expected trajectory, forecast risk, downside drivers, and the assumptions behind each scenario.
4.Industry Outlookp. 13
Growth drivers, risk factors, and external environment analysis. Unpacks the forces that will shape the industry over the forecast horizon — demographic shifts, regulatory changes, technology adoption, and cyclical exposure. Frames both the upside opportunities and the structural risks operators and investors should weigh.
5.Competitive Landscapep. 15
Market structure, concentration, barriers to entry, and competitive dynamics. Describes how the industry is structured between incumbents and entrants, typical competitive strategies, and what separates successful operators. Standard-tier reports add the official CR4, CR8, CR20, CR50 and HHI from the Census Economic Census, plus the largest public operators named from SEC EDGAR 10-K filings.
6.Operating Conditionsp. 18
Cost structure, labor requirements, technology factors, and the regulatory environment. Examines where operators spend, how sensitive margins are to input costs, what workforce and technology investments are typical, and which compliance and regulatory constraints shape day-to-day operations and long-term planning.
7.SWOT Analysisp. 20
Strengths, weaknesses, opportunities, and threats — each supported by concrete evidence from the underlying data. Moves beyond generic bullet points by tying each SWOT element to specific metrics, structural trends, or external forces identified elsewhere in the report. Useful for strategic planning and risk assessment.
8.Geographic BreakdownStandardp. 23
Regional market concentration, wage dynamics, and emerging geographic opportunities. Breaks establishments, employment, and payroll down by state and region, identifies where the industry is densest, where it is growing fastest, and how local labor markets and wage levels differ. Standard-tier and higher includes state-level tables.
9.Major Industry PlayersStandardp. 27
The largest public operators in the industry, named from their SEC EDGAR 10-K filings, with enterprise revenue and segment context. Sits alongside the official Census Economic Census concentration figures (CR4, CR8, CR20, CR50, HHI) so the named players can be read against the measured structure of the whole industry, public and private.
10.International TradeStandardp. 30
Import and export patterns and the industry's international market dynamics. Reviews how much of the industry is exposed to cross-border flows, which trading partners matter most, and how trade policy and currency shifts influence domestic operators. Included only when trade exposure is material.
Report Preview

Low-resolution overview of all 33 pages
Want to see a full report before you buy?
Download a free sample report →Industry Analysis
The Pharmaceutical preparation manufacturing industry (NAICS 325412) encompasses 1.4K establishments in the United States employing 170.0K workers (Census CBP, 2023), with 2026 revenue projected at ~$175.0B. Classified within Manufacturing, the industry is positioned in a mature phase of its life cycle.
This report examines historical performance trends (2012-2025), competitive structure, geographic distribution, and provides a 5-year outlook (2026-2030) with growth drivers, risk factors, and industry-specific SWOT analysis.
Products & Services
Key service categories in the Pharmaceutical preparation manufacturing industry.
Who Uses These Reports
Trusted by professionals who need verified federal data to make decisions
Investors & PE Firms
Size markets, validate deal theses, and benchmark targets with verified federal data before committing capital
Consultants & Advisors
Deliver data-backed recommendations to clients with sourced and cited industry metrics — Census, BLS, and FRED
Founders & Operators
Validate market entry, benchmark against industry averages, and present credible data to investors and boards
Corporate Strategy Teams
Support expansion planning, M&A due diligence, and executive reporting with NAICS-classified industry data
Top Questions Answered
What is the market size of the Pharmaceutical preparation manufacturing industry?
The Pharmaceutical preparation manufacturing industry generated ~$171.7B in revenue (US Census Annual Integrated Economic Survey, 2024). Across roughly 1.4K establishments employing 170.0K workers (Census CBP, 2023), it operates as a substantial national manufacturing base rather than a niche segment.
How fast is the Pharmaceutical preparation manufacturing industry growing?
The industry has followed a moderate expansion trajectory over the past decade, with revenue edging upward across the Economic Census periods. Employment rose over 2019-2023, which indicates the industry has been adding workers rather than contracting. The report breaks down how those two signals line up year by year.
What is the outlook for the Pharmaceutical preparation manufacturing industry?
Based on the historical trend, the industry is projected to continue its growth trajectory, with expansion expected to proceed at a measured pace rather than a sharp acceleration. This direction reflects the long-run pattern in revenue and the recent rise in employment. The report sets out how the forecast is built and what would change it.
How does the Census define the Pharmaceutical preparation manufacturing industry (NAICS 325412)?
The Census Bureau (NAICS 2017) defines NAICS 325412 as comprising "establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions." The scope therefore centers on finished dose-form products and in-vivo diagnostic substances. Biological preparations fall outside this code under the definition's own wording.
How many businesses operate in the Pharmaceutical preparation manufacturing industry?
The industry counts about 1.4K establishments (Census CBP, 2023) and employs 170.0K people (Census CBP, 2023). Spread across that many sites, the average establishment is large by manufacturing standards, which is why the industry carries a Highly Concentrated size label.
How competitive is the Pharmaceutical preparation manufacturing industry?
The industry carries a Highly Concentrated size label, a classification drawn from average establishment size rather than from a concentration ratio. With roughly 1.4K establishments (Census CBP, 2023) sharing 170.0K employees (Census CBP, 2023), the typical operation is a sizable production site rather than a small shop. That scale shapes the capital and staffing commitment needed to compete here.
Have wages in the Pharmaceutical preparation manufacturing industry kept up with inflation?
Over recent years, weekly wages in the industry kept pace with inflation, so workers' purchasing power was broadly maintained rather than eroded. That sits alongside rising employment over 2019-2023, meaning the industry added headcount without pay slipping behind prices. The report details the wage trend and how it compares across measures.
Who are the major players in the Pharmaceutical preparation manufacturing industry?
The industry's roughly 1.4K establishments (Census CBP, 2023) and Highly Concentrated size label point to an industry built around large production sites, with a wide base of operators beneath them. The establishment count shows a broad field of facilities, while the size label shows that the average site is substantial. The report covers how the industry's structure is measured and where publicly listed enterprise data adds context.
Get complete answers with detailed growth rates, forecasts, and competitive analysis.
Methodology
Every figure in this report is official US government data, computed in code and checked against the source by an automated validation pass. The text is drafted with AI, then read, reviewed and corrected where needed by a person. How we use AI
The Census Bureau's County Business Patterns and Economic Census provide establishment counts, employment, and payroll broken out by NAICS industry and geography. The Bureau of Labor Statistics QCEW program supplies wage data by industry. The Federal Reserve Economic Data (FRED) service contributes macroeconomic indicators used for industry forecasting — GDP, interest rates, housing starts, and sector-specific indices.
Data freshness varies by source: Census CBP has a ~2 year lag, BLS lags 6-9 months, and FRED provides near real-time macroeconomic data. Each report includes a data currency section showing exact year ranges.
Read our full methodology →Data Sources
Every chart, table, and claim in this report traces back to a published federal statistical database. Each data point in the PDF shows its source so you can verify it against the original dataset.
- U.S. Census Bureau — County Business Patterns & Economic Census
- Bureau of Labor Statistics — QCEW
- Federal Reserve Economic Data (FRED)
- SEC EDGAR — 10-K filings(Standard tier)
Report Details
Industry Classification (NAICS)
Where this industry sits in the North American Industry Classification System.